Summary
Smoking is one of the biggest avoidable causes of cancer. In the UK, smoking causes 3 in 20 cancer cases and one in five cancer deaths.
It has been proven that smoking can cause cancer in at least sixteen parts of the body: nose, mouth, voice box, throat, gullet, lung, breast, liver, stomach, kidney, pancreas, bowel, ovary, bladder, cervix, and bone marrow.
Smoking causes cancer by damaging the DNA inside cells. When people inhale tobacco smoke into their lungs the smoke also touches the nose, mouth, voice box, throat and gullet. But the dangerous chemicals in tobacco smoke can also damage organs that aren’t in the airway because they are absorbed into the bloodstream in the lungs.
Secondhand smoking is when a non-smoker breathes in tobacco smoke in the air caused by someone else smoking. It is also called passive smoking, involuntary smoking or environmental smoke. Secondhand smoking increases the chance of non-smokers developing lung cancer and cervical cancer.
Most of the cancer risks of cigarette smoking are true for cigars, pipes and waterpipes.
Introduction
This fact sheet reviews the risks of developing various types of cancer from smoking, other tobacco use and exposure to other people’s tobacco smoke.
It is estimated that half of all people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime[1]. Up to two in three long-term smokers are expected to die from a smoking-related disease.[2,3,4] Smoking is one of the single biggest avoidable risk factors for cancer.[5] Tobacco causes one in five of all cancer deaths in the UK (19%).[5]
Worldwide, one in five cancer deaths (21%) are caused by tobacco5, although they are at an earlier stage of the epidemic than high income countries.[6] Economically developing countries account for about 57% of all cancer cases and 65% of cancer deaths worldwide, with lung cancer now being the leading cause of cancer morbidity and mortality among men in these nations.[7] However, it is estimated that, as the tobacco epidemic matures, the future burden of tobacco-related cancers on less economically developed countries is expected to lead to a 70% increase in tobacco-related cancer cases.[8]
The 2004 IARC review, published by The Lancet Oncology, concludes that there is sufficient evidence to confirm that smoking is a cause of at least 15 types of cancer, namely, from the head down: paranasal sinuses and nasal cavity (nose), oral cavity (mouth, including lips and tongue), larynx (voice box), pharynx (throat), oesophagus (gullet), lung, liver, stomach, kidney & ureter, pancreas, colorectum (bowel), ovary (mucinous), bladder and cervix and myeloid leukaemia (a type of bone marrow cancer).[9] These have continued to be confirmed in subsequent publications, [10,11] with smoking listed among the “Carcinogenic agents with sufficient evidence in humans” on the IARC website for each of these parts of the body.[12] A 2004 US Surgeon General’s report had similar conclusions, finding “sufficient evidence” that smoking causes cancer of the oral cavity, larynx, pharynx, oesophagus, lung, stomach, ovary, kidney, pancreas, bladder and cervix, and myeloid leukaemia. It also concludes that the evidence is “suggestive” that smoking causes liver and colorectal cancers.[13]
Tobacco smoking is extremely well-established to be a cause of each of the 15 types of cancer listed above. In 2024, Cancer Research UK concluded that there was sufficient evidence to include breast cancer in the list of cancers caused by smoking.[14] There is more limited evidence to suggest that smoking may also be a cause of Hodgkin lymphoma, prostate cancer, and cancer of the vagina and vulva.
In the UK, smoking is particularly strongly associated with an increased risk of cancer of the lung, as well as the liver, bladder, kidney and pancreas.[15]
Some people are unable to quit smoking after a cancer diagnosis.[16,17]Continued smoking can limit the effectiveness of cancer treatments; increase the risk of complications and of developing additional primary and secondary cancers; increase pain; and reduce quality of life and survival.[16,18]
The risk of cancer may also be increased when smoking is combined with other unhealthy risk factors. For example, research suggests current and ex-smokers who drink 15+ units per week may be positively associated with smoking-related cancer deaths.[19] There is also evidence that alcohol can make it easier for the cancer-causing tobacco chemicals found in cigarettes to get into tissue and cells.[20,21]
Recent research is discovering how smoking causes cancer and damages DNA through cell mutations. Most of the mutations affect the tissues with direct exposure to smoke, such as in the lungs, but also in organs not directly exposed to smoke. Until recently, epidemiological research could only link smoking and cancer, but now the molecular changes caused by cigarette smoking can actually be quantified.[22,23,24] Additional research is needed to unlock the complexities of cancer development caused by smoking.
See also:
ASH Fact Sheet Smoking and respiratory disease
ASH Fact Sheet Smoking, the heart and circulation
ASH Fact Sheet Smoking, pregnancy and fertility
ASH Fact Sheet Smoking and mental health
ASH Fact Sheet Smoking and other health conditions
All head and neck cancers
Head and neck cancer includes cancer of the nose and sinuses, mouth, larynx and pharynx. Smokers have a higher risk of developing all types of head and neck cancers.[25,26] A yearly average of 13,800 new cases of head and neck cancer were recorded in the UK in 2019 and 2021-2022. Head and neck cancer incidence rates have increased by 41% in the UK since the early 1990s.[27] People who combine alcohol and tobacco use have a higher risk of head and neck cancers than would be expected by just combining the risks of each alone.[28]
A meta-analysis showed that the risk of head and neck cancers particularly increases with the length of time a person has been a smoker, as well as with the number of cigarettes consumed.[29] Quitting smoking reduces the risk of head and neck cancers.[29]
Paranasal sinuses and nasal cavity
Although nasal and sinus cancers are rare,[30] smoking significantly increases the risk of developing them.[31,32] Smoking appears to particularly increase the risk of for the squamous cell carcinoma type of sinonasal cancer.[33] A case-control study carried out in the United States found that heavy smokers had a two- to three-fold increased risk of nasal cancer and that there was also an increased risk associated with snuff use.[34]
Oral cavity
Cohort studies and meta-analyses have shown that smoking is a risk factor for cancer of the oral cavity.[35,36] Nearly one in five (17%) of oral cavity cancers in the UK are caused by smoking.[37] Oral cavity cancer is almost twice as high (91% higher) in current smokers compared with never smokers.[35]
People who combine alcohol or cannabis with tobacco use have a much higher risk of oral cancers than those using each of these substances individual.[38,39,40] Oral cavity cancer incidence rates in the UK are expected to continue to increase by a further 32% from 2014 to 2035.[41]
Larynx
Cigarette smoking is a major risk factor for cancers associated with the larynx,[23,42] and is linked to an estimated 64% of laryngeal cancer cases in the UK.[37] A case-control study found that the heaviest smokers have laryngeal cancer risks 20 times greater than never-smokers.[43] It has also been shown that the more one smokes and the longer one smokes, the greater the risk of laryngeal cancer.[44]
Pharynx
It has been estimated that smoking is a cause of 37% of cancers of the pharynx in the UK.[37] A meta-analysis showed that pharyngeal cancer risk is 3 times higher in current smokers compared with never-smokers.[45] Oropharyngeal cancer risk is almost twice as high in men in the heaviest- and longest-smokers versus the lightest- and shortest-smokers.[43] Similarly, nasopharyngeal cancer risk is three times as high in women among the heaviest- and longest-smokers compared with the lightest- and shortest-smokers.[46]
Oesophagus
Smoking is linked to an estimated 34% of oesophageal cancer cases in the UK.[37] Cigarette smoking is one of the main risk factors for both of the main types of oesophageal cancer; adenocarcinoma,[47] and squamous cell carcinoma.[48] The risk increases with the number of cigarettes smoked and duration of smoking and also remains elevated many years after smoking cessation.[49] There is a particularly poor prognosis for all-cause oesophageal cancer; only 13% of patients survive their disease for 10 years or more.[50]
Lung
Lung cancer has been estimated to be the most common cause of cancer deaths in the world for a number of decades.[51] It is also the most common type of cancer in the world.[52] In 2022, there were an estimated 2.5 million new cases of lung cancer worldwide, and an estimated 1.8 million deaths.[52] Lung cancer is the third most common cancer in the UK, accounting for about 11% of the total new cancer diagnoses.[53] In the UK, around 50,000 people were diagnosed with lung cancer each year 2019 and 2021-22 (nearly 140 every day).[53]
Lung cancer has the largest proportion of cases caused by smoking. In the UK about 72% of lung cancer cases[37] and 86% of lung cancer deaths, are attributable to tobacco smoking.[54] People are over 8 times as likely to develop lung cancer if they smoke, compared to never smokers.[55]
Because of its poor prognosis and relatively high prevalence, lung cancer is the most common cause of deaths due to cancer in the UK.[56] Only one in ten people with lung cancer in England will survive at least ten years beyond diagnosis.[57] In fact, since the majority of lung cancer cases are diagnosed at a late stage (stage 3 or 4), only 4 in 10 people diagnosed with lung cancer in England survive their disease for one year or more.[58]
A case-control study suggests that current smokers are 15 times more likely to die from lung cancer than life-long non-smokers.[59] The number of years a person has smoked for is the strongest determinant of lung cancer in smokers,[9,60] and the risk of dying from lung cancer is even higher in daily smokers than nondaily smokers.[59,61]
Smokers who start when they are young are at a particularly increased risk of developing lung cancer. A study by Professor Richard Peto and colleagues found that taking up smoking before the age of 15 doubles the risk of lung cancer compared to starting at the age of 20 or later, after taking into account the amount smoked.[62]
The study by Peto et al. also examined the effects of prolonged cigarette smoking and prolonged cessation on mortality from lung cancer.61 They found that if people who have been smoking for many years stop, even well into middle age, they avoid most of their subsequent risk of lung cancer. Also, stopping smoking before middle age avoids more than 90% of the risk attributable to smoking. Several other major studies have shown similar results.[63,64,65,66]
Quitting smoking even improves health and life expectancy after a diagnosis of lung cancer.[67,68] Despite the benefits of quitting, many smokers diagnosed with lung cancer continue to smoke even after treatment, with estimates ranging from 13% to 60%.[69]
See also: ASH Fact Sheet Smoking and respiratory disease
Breast
Most older studies found no association between smoking and breast cancer but studies published since 2000 show evidence for a link.[70] An expert panel in Canada reviewed the results of cohort studies and concluded that risk of breast cancer is 10% to 30% higher in long-term smokers than nonsmokers.[71] Other studies suggest that the increase in breast cancer risk from smoking mostly affects pre-menopausal women,[72,73,74] although a British study of middle-aged women found no evidence of an association with either active or passive smoking.[75] A number of studies over the past decade have suggested causation.[76,77,78,79,80]
As of IARC’s 2012 classification, it considers the evidence for smoking as a causal factor for breast cancer to be limited.[11[ The US Surgeon General’s report of 2014 concluded that:
“1. The evidence is sufficient to identify mechanisms by which cigarette smoking may cause breast cancer. [...]
“3. The evidence is suggestive but not sufficient to infer a causal relationship between active smoking and breast cancer. [...]”[81]
In light of the evidence for a connection between smoking and breast cancer some commentators have urged the IARC to re-review the evidence.[82] In 2024, Cancer Research UK concluded that there was sufficient evidence to include breast cancer in the list of cancers caused by smoking.[14]
Liver
Large studies have demonstrated an association between smoking and risk of liver cancer.[83,84] It is estimated that one in five (20%) of liver cancer cases in the UK are caused by smoking.[85]
In many studies, as with cancer of other organs, the risk increases with duration of smoking or number of cigarettes smoked daily.[86] Similar to lung cancer, by the time any symptoms appear, liver cancer is typically at an advanced stage, leaving limited options for treatment.[87] Liver cancer incidence rates are accelerating in the UK and are expected to increase to 43% in men and 21% in women from 2014 to 2035.[41]
People who have a Hepatitis B or C infection have around a 20 times higher risk of hepatocellular liver cancer, and it is increased even further if they smoke, with greater increases in risk shown for people who smoke and are also infected with hepatitis viruses.[88]
Stomach
Stomach cancer rates have been in decline in recent years but it remains the fifth most common cancer in the world and the fifth most common cause of cancer death.[89] Studies have long shown a consistent association between cigarette smoking and cancer of the stomach.[90,91,92,93] An estimated 15% of stomach cancers in the UK are linked to smoking.[37]
Current smokers who smoke daily have almost twice the risk of stomach cancer compared to never-smokers.[94] Risk increases with duration of smoking and number of cigarettes smoked.94 There is some evidence that the risk decreases with smoking cessation.[95,96,97]
Kidney
In the UK, kidney cancer accounts for 4% of all new cancers in men and 3% in women.[98] Although comparatively rare, kidney cancer has consistently been found to be more common in smokers than in non-smokers and there is sufficient evidence to show that smoking is a risk factor for kidney cancer.[99,100,101]
Kidney cancer risk is a third (33%) higher in current smokers compared with non-smokers.[102] There is a dose-response relationship, with a higher risk the greater the number of cigarettes smoked per day.[99] Smoking more than 20 cigarettes a day can double the risk in male smokers of the most common type of kidney cancer (renal cell cancer) compared to never-smokers. For women, the risk is over one-and-a-half times greater. Risk appears to reduce after smoking cessation.[100]
Tobacco smoking has been shown to cause cancer of the ureter (a tube that carries urine from the kidney to the urinary bladder) in both men and women.[103,104] Even though this is a relatively rare type of cancer, smoking is one of the few major risk factors.[105] Smoking also worsens the prognosis of people who have cancer of the ureter.[106]
Kidney cancer incidence rates are expected to continue to increase by a further 28% in men and 18% in women from 2014 to 2035 in the UK.[41]
Pancreas
Cancer of the pancreas typically has poor prognosis because it is often diagnosed at a late stage.[107] A quarter (25%) of people diagnosed with pancreatic cancer in the UK survive their disease for one year or more and 4% survive for ten years or more.[108] Smoking is the single most significant risk factor for pancreatic disease [109,37] and is estimated to be responsible for 11-32% of pancreatic cancer worldwide. [110,111] Cigarette smoking is linked to 22% of cases of pancreatic cancer in the UK. [37]
Risk of pancreatic cancer is related to amount and duration of smoking.[112,113] A cohort study suggests, smokers are almost twice as likely to develop pancreatic cancer as people who have never smoked.[114] A 2012 study calculated a 27% increased risk of pancreatic cancer for every five cigarettes smoked per day.[115]
The risk of pancreatic cancer can diminish after cessation. Research has shown it takes around 20 years for the level of cancer risk of an ex-smoker to fall to the level of someone who has never smoked,[113,116] although estimates vary.[117]
With the reduction in smoking among men over the last several decades, a study in Australia showed that the mortality rate of pancreatic cancer among men has also decreased.[118] It is expected that this change will also occur in women in Australia and other economically developed countries as smoking rates are further reduced.
Colorectal
Colorectal cancer is the third most common type of cancer globally,[88] and the second most common cause of cancer deaths. Smoking is a cause of colorectal (bowel) cancer.[119,120] Smoking is linked to an estimated 7% of bowel cancers in the UK.[37] Colorectal cancer risk is 17-21% higher in current cigarette smokers compared with never-smokers.[118]
A recent meta study found that the risk of colorectal cancer increases with greater smoking intensity and duration.[121] Long-term smokers are more likely than never-smokers to have and die from colorectal cancer. Continued smoking after diagnosis increases the risk of death.[122]
Ovary
Ovarian cancer is the sixth most common cancer in women in the UK.[123] Less than 1% of all ovarian cancers in the UK are deemed to be caused by smoking.[37]
Smoking increases women’s risk for particular sub-type of the disease, mucinous ovarian cancer, by 31-49%.[124,125] The risk of developing mucinous ovarian cancer increases with the length of time a woman has smoked.[123, 124]
Bladder
Tobacco smoking is the single largest preventable risk factor for bladder cancer.[126,127] Smoking is linked to an estimated 45% of bladder cancer cases in the UK.[37]
The risk of developing bladder cancer is 2-4 times higher in smokers than in people who have never smoked.[128,129,130] The incidence of bladder cancer is 3-4 times higher among men than women in the UK.[131]
As with many other types of cancer, the risk is associated with both the dose and duration of smoking.[132] People who stop smoking reduce their risk, although they remain at higher risk than never-smokers for over 25 years after they quit.[131,133,134]
Cervix
Cervical cancer is almost always in part caused by high-risk human papillomavirus (HPV) infection,[135] but smoking is also known to increase the risk. In the UK, it is estimated that around one in five (21%) of cervical cancer cases are linked to smoking.[37]
It is not yet fully understood how the risk factors of smoking and HPV interact in cases of cervical cancer,[136] but smoking appears to particularly increase the risk of squamous cell carcinoma.[137,138] The risk of cervical squamous cell carcinoma is increased by the number of cigarettes smoked and starting smoking at a young age.[139]
An analysis of epidemiological studies concluded that risk of cervical cancer is increased by 60% in current smokers.[140] A US study found that continued smoking among cancer survivors may increase their risk of subsequent tobacco-related malignancies and related death. Despite the risks, almost 40% of women diagnosed with cervical cancer are estimated to continue smoking after diagnosis.[141] As with other cancers, stopping smoking can halt the growth of the cancer and reduce early cervical lesion size in women who give up smoking after diagnosis.[142,143]
Myeloid leukaemia
Leukaemia is a cancer of the white blood cells and bone marrow. There are four main types of leukaemia: acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML) and chronic lymphocytic (CLL).[144] Smoking increases the risk of both acute and chronic myeloid leukaemia,[145,146,9] and is linked to around 3% of all leukaemia cases in the UK.[37]
Emerging evidence
There is overwhelming evidence for the impact of smoking on a range of cancers. In addition to those already discussed, there is emerging evidence for links to additional cancer sites.
Hodgkin lymphoma
Hodgkin lymphoma, a cancer of the lymphatic system that starts in white blood cells called lymphocytes,[147] is a relatively rare type of cancer accounting for 1% of all cancer cases in the UK in 2019 and 2021/22.[148]
Several major studies suggest an increased risk for Hodgkin lymphoma in smokers.[149,150] In general Hodgkin lymphoma carries a 10-15% higher risk in ever-smokers than never-smokers.[148,149,151] Smoking may especially increase the risk for older men and the risk of certain types of Hodgkin lymphoma, such as those associated with the Epstein–Barr virus.[150]
The Million Women Study, which followed outcomes for British women between 1996 and 2001, revealed that the risks of Hodgkin lymphoma and mature T-cell lymphomas were doubled in women who smoked around 15 or more cigarettes a day. The risks of other types of haematological (blood) cancer were also increased among smokers, but to a lesser extent.[152]
Prostate
The 2004 US Surgeon General’s Report states that, “The evidence is suggestive of no causal relationship between smoking and risk for prostate cancer.”[153] The IARC report from 2012 agrees that most studies have not shown a consistent correlation between smoking and prostate cancer.[11]
However, since these reports were issued, new research has found that smoking may increase the risk of prostate cancer[154,155] and that heavy smokers have a 24-30% increased risk of death from prostate cancer.[156] Smoking may also increase the risk of recurrence of prostate cancer.[157,158]
Additional research is needed before being able to determine definitively if smoking causes prostate cancer.
Endometrium (womb)
Smoking does not increase the risk of endometrial (womb) cancer. In fact, a body of evidence shows that smoking can be protective against endometrial cancer, especially in post-menopausal women and long-term, heavy smokers. [159,160,161] One meta-analysis found that post-menopausal smokers had a 29% reduced risk compared with never-smokers.[162]
Given the strong causal link between smoking and other cancers, any reduced endometrial cancer risk among female smokers is not directly relevant to public health[163] and smoking should still be strongly discouraged.
Vulva and vagina
Although not included in the latest IARC review of cancers caused by smoking, some studies suggest an association between smoking and cancer of the vulva and vagina.[164] One study reported at least double the risk for vulvar and vaginal squamous cell carcinoma in women who smoke and have high-risk HPV compared to lifelong non-smokers with the virus.[165] Smoking is among the most well established HPV cofactors in the etiology of vulvar cancer,[166] and rates of vulvar cancer are higher in countries with high smoking prevalence.[167]
Secondhand smoke (Passive smoking/environmental smoke)
Adults
Since 2004, IARC has stated that “there is sufficient evidence that involuntary smoking (exposure to secondhand or ‘environmental’ tobacco smoke) causes lung cancer in humans.”[9] This conclusion was echoed by the US Surgeon General’s report in 2006.[168] The IARC further confirmed that secondhand smoke can cause lung cancer in never smokers in their 2012 publication ‘Personal Habits and Indoor Combustions’.[11] Non-smokers are at risk of lung cancer from exposure to other people's smoke, particularly if they are genetically predisposed[169, 170, 171] or if the exposure is long-term.[172,173]
The UK's Scientific Committee on Tobacco and Health (SCOTH) reported an increased risk of lung cancer in non-smokers of between 20% and 30% from secondhand exposure to smoke.[174] A subsequent review of the evidence by SCOTH in 2004 confirmed that the increased risk was around 24%.[175] In cases of very high exposure, the risk of lung cancer can even double.[176] It is estimated that in the UK 15% of lung cancer cases in never smokers are caused by exposure to secondhand smoke.[37]
A meta-analysis has shown that the risk for cervical cancer is 73% higher in never-smokers exposed to secondhand smoke, compared to those who are not exposed.[177] However, it is not clear whether the relationship is causal.
The 2012 IARC update reports limited evidence showing an association between exposure to secondhand smoke and cancers of the larynx and pharynx.[11] As for nasal cancer, the 2006 US Surgeon General’s report concluded that, “the evidence is suggestive but not sufficient to infer a causal relationship” between secondhand smoke exposure and a risk of both nasal sinus cancer and nasopharyngeal carcinoma among non-smokers.[167]
IARC also reported in 2012 and the US Surgeon General in 2014 that the evidence linking secondhand smoke to breast cancer is inconclusive but suggestive.[11,178] Some scientists are urging that a causal link between breast cancer and secondhand smoke be declared by authoritative organizations, but some studies show the link only in pre-menopausal women with certain genetic variants.[179,180,181] Exposure to secondhand smoke in young women between menarche and their first full-term pregnancy seems to be particularly harmful.[182]
Recent studies have found a possible link between secondhand smoke and many other types of cancer,[183] including oral[184] and bladder.[185]
More research is needed in all these areas except for lung cancer to determine causality.
See also:
ASH Key Topic Secondhand smoke
ASH Fact Sheet Secondhand smoke
Thirdhand smoke
Thirdhand smoke is made up of the residual gases and particles that stick to surfaces and that are found in dust wherever people smoke indoors. Research indicates a possible link between thirdhand smoke and lung cancer,[186,187] and that thirdhand smoke can cause biological changes in mice.[188] However, there is not yet a body of evidence large enough to infer causality.
Children
It is well-established that prenatal and postnatal exposure to tobacco smoke is harmful to foetuses, infants and children, worsening asthma and increasing the risk of stillbirth.[189,190,191]
The evidence about the risks of secondhand smoke in children’s cancers is emerging and inconsistent.[192] In 2006, the US Surgeon General concluded that, “The evidence is suggestive but not sufficient to infer a causal relationship between prenatal and postnatal exposure to secondhand smoke and childhood cancer.”[167]
Children who are exposed to tobacco smoke on a daily basis grow up to have more than triple the risk of lung cancer as adults compared to those who grow up in smokefree environments.[193] Furthermore, exposure to tobacco smoke during childhood may lead to head and neck squamous cell carcinoma later in life, although the research is limited on this topic.[194]
Exposure to parental smoking is a cause of hepatoblastoma (a type of liver cancer) in children,[195] supported by the IARC which includes parental tobacco smoke as a carcinogenic agent to the liver with sufficient evidence in humans.[12]
There is some evidence that children of smokers have an increased risk of childhood leukaemia, according to IARC and others.[11,196] Additional research suggests that heavier paternal smoking around the time of conception may be a risk factor for childhood acute lymphoblastic leukaemia (ALL).[197,198] ALL is the most common form of leukaemia in children.
Further research is needed to support any emerging research, as well as to break new ground in linking tobacco smoke to other childhood cancers or cancers later in life for those who had long-term childhood exposure.
See also:
ASH Fact Sheet Young people and smoking
ASH Key Topic Youth Smoking
Smokeless Tobacco
Smokeless tobacco is tobacco that is chewed, sucked or sniffed, such as chewing tobacco, moist snuff and snus. It excludes e-cigarettes (vapes) as they do not contain tobacco, although like cigarettes and smokeless tobacco they normally contain nicotine. In 2007, IARC concluded that there is sufficient evidence in humans to state that smokeless tobacco causes cancer of the mouth, oesophagus and pancreas.[10,199,200]This evidence was reconfirmed by IARC in 201211, but a 2014 review found insufficient evidence to declare smokeless tobacco a cause of pancreatic cancer.[201]
Long-term use of smokeless tobacco increases the risk of head and neck squamous cell carcinoma, especially for snuff users.[202,203,204]
The 2012 IARC updates also concluded that “switching from cigarette smoking to smokeless tobacco significantly increased the risk for lung cancer compared to never-tobacco users, and the risk was of greater magnitude than for quitting all together.”[11]
Animal studies point to the additional possibility of smokeless tobacco causing cancer of the forestomach and skin, but epidemiological studies are inconclusive at this stage.[205]
Ongoing research is needed by type of smokeless tobacco and among people who only use a specific product and those who use it in conjunction with other smokeless tobacco product(s) or cigarettes.
Waterpipes
Waterpipes (also known as hookah, shisha or narghile) have recently increased in popularity, especially among youth and young adults who may consider them “healthier” than smoking cigarettes. Using a waterpipe is not safer than smoking. In fact, it contains 27 known or suspected carcinogens.[206]
There is sufficient evidence to link waterpipe smoking to lung cancer, and some evidence linking shisha use to oral cancer, leukaemia, oesophageal squamous cell carcinoma, stomach and possibly other cancers.[207,208,209,210,211,212]
Waterpipe smoking may more than double the risk of lung cancer.[213,214] Additional research is required to definitively assess the relative risks,[215] but the body of evidence that waterpipes cause cancer is increasing.
Cigars and pipes
Cigar, pipe and cigarette smoking carry many of the same risks.[216] People who smoke cigars only – with no history of smoking cigarettes or pipes – are at risk of several types of cancer. A 2015 systematic review and the IARC 2004 report both concluded that cigar and/or pipe smoking can cause cancers of the lung, oral cavity, pharynx, larynx, esophagus and pancreas.[216,9] Another study also indicated an increased risk for liver cancer in both cigar and pipe smokers.[217]
Strong daily cigar use and inhalation, which are relatively rare except among current or former cigarette smokers, further increase the risk for oral, esophageal, laryngeal, and lung cancers.[216] Even without inhalation, the relative mortality risk is still high for oral, esophageal, and laryngeal cancers.[216]
References
Please cite as: Action on Smoking and Health (ASH). Smoking and Cancer. 2026.
Online links last checked November 2026.
- Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in Great Britain: Comparison of risk for those born in 1930 to 1960. Br J Cancer bjc.2014:606, 2015
- Pirie K, Peto R, Reeves G et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. The Lancet, 2012
- Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors BMJ 2004; 328 :1519
- Banks e et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med 13, 38 (2015)
- Institute for Health Metrics and Evaluation. Global Burden Study of Disease, 2023
- Lee YC, Hashibe M. Tobacco, alcohol, and cancer in low and high income countries. Ann Glob Health. 2014 Sep-Oct;80(5):378-83
- Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65: 87-108 (2015)
- Lee YC, Hashibe M. Tobacco, alcohol, and cancer in low and high income countries. Ann Glob Health. 2014 Sep-Oct;80(5):378-83
- Tobacco smoke and involuntary smoking. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 83 IARC, 2004
- Smokeless Tobacco and Some Tobacco -specific N-Nitrosamines. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 89 IARC, 2007
- Personal Habits and Indoor Combustions IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 100E IARC, 2012
- International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans [Accessed November 2026]
- Centers for Disease Control and Prevention, Washington, D.C. The health consequences of smoking: a report of the Surgeon General. Dept. of Health and Human Services, 2004
- Cancer Research UK. Breast cancer and smoking: What is the link? July 2024.
- Jacob L, Freyn M, Kalder M, Dinas K, Kostev K. Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years. Oncotarget. 2018 Apr 3;9(25):17420-17429
- Florou AN et al. Clinical significance of smoking cessation in subjects with cancer: a 30-year review. Respir Care. 2014 Dec;59(12):1924-36
- Gabriella E Puleo, MS, Tia Borger, MS, William R Bowling, BA, Jessica L Burris, PhD, The State of the Science on Cancer Diagnosis as a “Teachable Moment” for Smoking Cessation: A Scoping Review, Nicotine & Tobacco Research, Volume 24, Issue 2, 2022, p160–168
- Karam-Hage M1, Cinciripini PM, Gritz ER. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014 Jul-Aug;64(4):272-90
- Hart CL et al. The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort. BMC Public Health 2010 10:789
- Boffetto P. Alcohol and cancer. The Lancet Oncology 2006; 7 (2): p149–156
- Centers for Disease Control and Prevention (US) How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. 2010 p297-298
- Alexandrov LB, Ju YS, Haase K, et al. Mutational signatures associated with tobacco smoking in human cancer. Science. 2016 Nov 4;354(6312):618-622
- Ma, Y., Li, M.D. Establishment of a Strong Link Between Smoking and Cancer Pathogenesis through DNA Methylation Analysis. Sci Rep 7, 1811 (2017)
- Baglietto, L et al. (2017), DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk. Int. J. Cancer, 140: 50-6
- Lee YC, Marron M, Benhamou S et al. Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study. Cancer Epidemiol Biomarkers Prev. 2009; 18(12): 3353-61
- Cancer Research UK. Head and neck cancers risk. [Accessed November 2026]
- Cancer Research UK. Head and neck cancer incidence. [Accessed November 2026]
- D. Hashim, E. Genden, M. Posner, M. Hashibe, P. Boffetta, Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden, Annals of Oncology, Volume 30, Issue 5, pp744-756, 2019
- Scott L. Tomar, Duration of Cigarette Smoking Is a Stronger Risk Factor Than Number of Cigarettes Smoked per Day for Head and Neck Cancer, and Quitting Dramatically Lowers the Risk, Journal of Evidence Based Dental Practice, Volume 20, Issue 1, 2020
- Cancer Research UK. Nasal and paranasal sinus cancer – Risks and causes [Accessed November 2026]
- Vineis P, Alavanja M, Buffler P et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004; 96(2): 99-106
- Youlden DR et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013 Dec;37(6):770-9
- 't Mannetje A, Kogevinas M, Luce D, Demers PA, Begin D, Bolm-Audorff U et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med 1999;36(1):101-107
- Brinton LA, Blot WJ, Becker JA et al. A case-control study of cancers of the nasal cavity and paranasal sinuses. American Journal of Epidemiology 1984; 119 (6): 896-906
- Maasland DH, van den Brandt PA, Kremer B, at al. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study. BMC Cancer. 2014
- Lubin JH, Muscat J, Gaudet MM et al. An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies. Cancer Causes Control. 2011
- Brown, K.F., Rumgay, H., Dunlop, C. et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer 118, 1130–1141 (2018)
- Turati F, Garavello W, Tramacere I et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers: Results from subgroup analyses. Alcohol and Alcoholism 2013; 48(1):107-18.
- Hashibe M, Brennan P, Chuang SC et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009; 18(2): 541-50.
- Lopes C. et al. Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: recent advances and challenges. Arch Oral Biol. 2012
- Smittenaar, C., Petersen, K., Stewart, K. et al. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer 115, 1147–1155 (2016)
- Christensen, CH, Rostron B, Cosgrove C Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population JAMA Intern Med. 178(4):469–476 (2018)
- Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, Negri E, Pasche C, Vaccarella S, Barzan L, Franceschi S. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 2002 Dec;13(10):957-64. doi: 10.1023/a:1021944123914. PMID: 12588092.
- Zuo, JJ., Tao, ZZ., Chen, C. et al. Characteristics of cigarette smoking without alcohol consumption and laryngeal cancer: overall and time-risk relation. A meta-analysis of observational studies. Eur Arch Otorhinolaryngol 274, 1617–1631 (2017)
- Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008; 122(1):155-64.
- Long M, Fu Z, Li P, et al. Cigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studies. BMJ Open 2017
- Thrumurthy SG, Chaudry, MA, Thrumurthy SSD, Mughal M Oesophageal cancer: risks, prevention, and diagnosis BMJ 366:l4373 (2019)
- Thrift AP. The epidemic of oesophageal carcinoma: Where are we now? Cancer Epidemiol. 2016 Apr;41:88-95
- Zhang Y Epidemiology of esophageal cancer. World J Gastroenterol. 2013 Sep 14;19(34):5598-606
- Cancer Research UK Oesophageal cancer survival statistics [Accessed November 2026]
- Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143
- WHO International Agency for Research on Cancer. Lung cancer fact sheet [Accessed November 2026]
- Cancer Research UK Lung cancer incidence [Accessed November 2026]
- Cancer research UK. Lung cancer risk. [Accessed November 2026]
- Lee, P.N., Forey, B.A. & Coombs, K.J. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 12, 385 (2012)
- Cancer research UK Lung cancer mortality statistics [Accessed November 2026]
- Cancer research UK Lung cancer survival statistics [Accessed November 2026]
- Office for National Statistics Cancer survival by stage at diagnosis for England (experimental statistics): Adults diagnosed 2012, 2013 and 2014 and followed up to 2015. 2016. ONS
- Schwartz, A.G., Cote, M.L. Epidemiology of Lung Cancer. In: Ahmad, A., Gadgeel, S. (eds) Lung Cancer and Personalized Medicine. Advances in Experimental Medicine and Biology, vol 893 2016
- Inoue-Choi M, Christensen CH, Rostron BL, et al. Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States. JAMA Netw Open. 2020
- Remen, T., Pintos, J., Abrahamowicz, M. et al. Risk of lung cancer in relation to various metrics of smoking history: a case-control study in Montreal. BMC Cancer 18, 1275, 2018
- Peto R, Darby S, Deo H et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ, 2000; 321: 323-9.
- The Tobacco Atlas Cessation [Accessed November 2026]
- Pirie K, Peto R, Reeves GK et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. The Lancet 2013; 381 (9861): 133- 141
- Tindle HA, Duncan MS, Greevy RA, Vasan RS, Kundu S, Massion PP, Freiberg MS, Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study, JNCI: Journal of the National Cancer Institute, Volume 110, Issue 11, November 2018, Pages 1201–1207
- Jha P, Ramasundarahettige C, Landsman V et al. 21st century hazards of smoking and benefits of cessation in the United States. NEJM 2013; 368: 341-350
- Caini S et al. Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology Volume 17, Issue 5, May 2022, p623-636
- Sheikh M, Mukeriya A, Shangina O. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality. Annals of Internal Medicine 2021 Volume 174 Issue 9 P1232-1239
- Walker M, Vidrine DJ, Gritz ER et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epdimiol Biomarkers Prev 2006; 15(12): 2370-7
- Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, Ockene JK, Prentice RL, Speizer FE, Thun MJ, Jacobs EJ. Smoking and mortality--beyond established causes. N Engl J Med. 2015 Feb 12;372(7):631-40
- Johnson KC, Miller AB, Collishaw NE et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on tobacco smoke and breast cancer risk (2009). Tobacco Control 2011; 20(1)
- Johnson, KC. Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 2005; 117: 619-628
- Abramowitz MC, Tianyu LMS, Morrow M, Anderson PR. History of smoking is associated with younger age at diagnosis of breast cancer. The Breast Journal. 2010; 16 (4): 344-349.
- Xue F, Willett WC, Rosner BA et al. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171(2):125-133.
- Roddam AW, Pirie K, Pike MC et al. Active and passive smoking and the risk of breast cancer in women aged 36-45 years: a population-based case-control study in the UK. Br J Cancer 2007 Aug 6;97(3):434-9
- Mia M. Gaudet, Susan M. Gapstur, Juzhong Sun, W. Ryan Diver, Lindsay M. Hannan, Michael J. Thun, Active Smoking and Breast Cancer Risk: Original Cohort Data and Meta-Analysis, JNCI: Journal of the National Cancer Institute, Volume 105, Issue 8, 17 April 2013, Pages 515–525
- Kawai M, Malone KE, Tang MT, Li CI. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Cancer. 2014 Apr 1;120(7):1026-34. doi: 10.1002/cncr.28402. Epub 2014 Feb 10
- Dossus L et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014 Apr 15;134(8):1871-88
- AJ White, AA D'Aloisio, HB Nichols, LA DeRoo, DP Sandler Active Tobacco Smoke and Environmental Tobacco Smoke Exposure During Potential Biological Windows of Susceptibility in Relation to Breast Cancer. Cancer Epidemiol Biomarkers Prev 1 March 2016; 25 (3): 562
- Gaudet MM et al. Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies. Int J Epidemiol. 2017 Jun 1;46(3):881-893
- U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. p283, 2014. Printed with corrections, January 2014
- Glantz SA, Johnson KC. The surgeon general report on smoking and health 50 years later: breast cancer and the cost of increasing caution. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):37-46
- Lee YC, Cohet C, Yang YC et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol. 2009 Dec; 38(6):1497-511
- Abdel-Rahman O, Helbling D, Schöb O et al. Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies. J Evid Based Med. 2017
- Cancer Research UK. Liver cancer risk. [Accessed November 2026]
- Koh WP, Robien K, Wang R, et al. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer. 2011 Oct 25;105(9):1430-5.
- Shire AM, Roberts LR. Prevention of hepatocellular carcinoma: progress and challenges. Minerva Gastroenterol Dietol. 2012 Mar;58(1):49-64
- Chuang SC, Lee YC, Hashibe M et al. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024
- Centers for Disease Control and Prevention, Washington, D.C. The health consequences of smoking: a report of the Surgeon General. Dept. of Health and Human Services p178-208, (2004)
- Tredaniel J, Boffetta P, Buiatti E, et al. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997 Aug 7;72(4):565-73
- La Torre G, Chiaradia G, Gianfagna F, et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori. 2009; 95: 13 – 22
- Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008; 19: 689 – 701
- Sjödahl K, Lu Y, Nilsen TI et al. Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer. 2007; 120(1):128-32
- González CA, Pera G, Agudo A et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 2003; 107 (4): 629-34
- Caini, S. et al. S. The Prognostic Impact of Quitting Smoking at or around Diagnosis on the Survival of Patients with Gastrointestinal Cancers: A Systematic Literature Review. Cancers 2022, 14, 3857
- Praud, D. et al Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project. European Journal of Cancer Prevention, Volume 27, Number 2, pp. 124-133(10) 2018
- Cancer Research UK Kidney cancer incidence statistics [accessed November 2026]
- Cumberbatch MG, Rota M, Catto JW, et al. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks . Eur Urol. 2016 Sep;70(3):458-66
- Hunt, J.D., van der Hel, O.L., McMillan, G.P., Boffetta, P. and Brennan, P. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int. J. Cancer, 114: 101-108. 2005
- Huang J et al. A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome. European Urology Focus, Volume 8, Issue 1, p200-209 (2022)
- Cumberbatch MG, Rota M, Catto JW,et al. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. Eur Urol. 2016
- Pommer W, Bronder E, Klimpel A, et al. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics, and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant. 1999;14:2892–7.
- Jensen OM, Knudsen JB, McLaughlin JK, et al. The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures. Int J Cancer. 1988; 41:557–61
- Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol. 2003 Aug; 47(2):155-69
- Xylinas E, Kluth LA, Rieken M, et al. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int 2014
- Cancer Research UK Survival for pancreatic cancer [Accessed November 2026]
- Cancer Research UK Pancreatic cancer survival statistics [Accessed November 2026]
- Alsamarrai A, Das SL, Windsor JA, Petrov MS. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol. 2014 Oct;12(10)
- Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015 Feb;44(1):186-98
- Wörmann SM, Algül H. Risk factors and therapeutic targets in pancreatic cancer. Front Oncol. 2013 Nov 18;3:282
- Ben, Q-W et al. Cigarette Smoking and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis. Pancreas: September 2019 - Volume 48 - Issue 8 - p 985-995
- Molina-Montes E et al. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships. Cancer Epidemiol Biomarkers Prev 1 May 2020; 29 (5): 1009–1018
- Heinen MM, Verhage BA, Goldbohm RA, van den Brandt PA. Active and passive smoking and the risk of pancreatic cancer in the Netherlands Cohort Study. Cancer Epidemiol Biomarkers Prev. 2010; 19 (6):1612-22.
- Leenders M, Chuang SC, Dahm CC, et al. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Int J Cancer (2012) 131(4):997–1002
- Bosetti C et al. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol. 2012 Jul;23(7):1880-8
- Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC et al. Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010; 126(10): 2394-403
- Adair T, Hoy D, Dettrick Z, Lopez AD. Tobacco consumption and pancreatic cancer mortality: what can we conclude from historical data in Australia? Eur J Public Health. 2012 Apr;22(2):243-7
- Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009; 124: 2406-2415.
- Richard Boland CR, Goel A. Clearing the Air on Smoking and Colorectal Cancer. J Natl Cancer Inst 2010 Jul 21;102(14):996-7
- Botteri, E et al. Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis. The American Journal of Gastroenterology: December 2020 - Volume 115 - Issue 12 - p 1940-1949
- Walter V, Jansen L, Hoffmeister M, Brenner H. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol. 2014 Aug;25(8):1517-25
- Cancer Research UK Ovarian cancer incidence [Accessed November 2026]
- Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R. Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol. 2012 Sep;13(9):946-56
- Faber MT et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control. 2013 May;24(5):989-1004
- Cancer Research UK Bladder cancer risk [Accessed November 2026]
- Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol. 2016 Sep;31(9):811-51
- Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011 Aug 17;306(7):737-45
- Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. Eur Urol. 2016 Sep;70(3):458-66
- van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol. 2016 Jun;45(3):857-70
- Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2016 Feb;69(2):300-10
- Mori K Mostafaei H, Abufaraj M, Yang L Egawa S, Shariat SF. Smoking and bladder cancer: review of the recent literature. Current Opinion in Urology: September 2020 - Volume 30 - Issue 5 - p 720-725
- Brennan P, Bogillot O, Cordier S, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer. 2000 15;86(2):289-94
- Brennan P, Bogillot O, Greiser E. et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 2001; 12(5): 411-7
- Cancer Research UK Cervical cancer risk – Human papillomavirus (HPV) [Accessed November 2026]
- Nagelhout et al. Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis. Expert Review of Anticancer Therapy. 2021 Mar Vol 21 Issue 7 p781-794
- International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007 15;120(4):885-91
- Berrington de González A, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer. 2004 May 4;90(9):1787-91.
- Frits HM van Osch, Sylvia HJ Jochems, Frederik-Jan van Schooten, Richard T Bryan, Maurice P Zeegers, Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies, International Journal of Epidemiology, Volume 45, Issue 3, June 2016
- International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006 Mar 15;118(6):1481-95
- Underwood JM, Rim SH, Fairley TL, Tai E, Stewart SL. Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992-2008. Cancer Causes Control. 2012 Jul;23(7):1009-16
- Szarewski A, Jarvis MJ, and Sasieni, P. Effect of smoking cessation on cervical lesion size. The Lancet 1996; 347: 941-943
- Roura E et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer 2014 Jul 15;135(2):453-66
- Cancer Research UK Leukaemia [Accessed November 2026]
- Brownson RC, Novotny TE, Perry MC. Cigarette Smoking and Adult Leukemia: A Meta-analysis. Arch Intern Med. 1993
- J. McLaughlin et al. Cigarette Smoking and Leukemia, JNCI: Journal of the National Cancer Institute, Volume 81, Issue 16, 16 August 1989
- Cancer Research UK What is Hodgkin lymphoma? [Accessed November 2026]
- Cancer Research UK Hodgkin lymphoma incidence [Accessed November 2026]
- Castillo JJ, Dalia S, Shum H. Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma. J Clin Oncol. 2011 Oct 10;29(29):3900-6
- Sergentanis TN, Kanavidis P, Michelakos T, Petridou ET. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. Eur J Cancer Prev. 2013 Mar;22(2):131-50
- Kamper-Jørgensen M, Rostgaard K, Glaser SL, et al. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Ann Oncol 2013;24(9):2245-55.
- Kroll ME et al. Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study. Br J Cancer. Aug. 2012
- Centers for Disease Control and Prevention, Washington, D.C. The health consequences of smoking: a report of the Surgeon General. Dept. of Health and Human Services p250-252 (2004)
- Islami F, Moreira DM, Boffetta P, Freedland SJ. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol. 2014 Dec;66(6):1054-64
- Rohrmann S et al. Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2013 Feb 19;108(3):708-14
- Huncharek M, Haddock KS, Reid R, et al. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010;100:693-701
- Rieken M et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. 2015 Dec;68(6):949-56
- Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database. Cancer. 2014 Jan 15;120(2):197-204
- Centers for Disease Control and Prevention, Washington, D.C. The health consequences of smoking: a report of the Surgeon General. Dept. of Health and Human Services p172-177 (2004)
- Felix AS, Yang HP, Gierach GL, Park Y, Brinton LA. Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes Control. 2014 Apr;25(4):479-89
- Yang HP, Brinton LA, Platz EA, Lissowska J, Lacey JV Jr, Sherman ME, Peplonska B, Garcia-Closas M. Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer. 2010 Mar;46(4):690-6
- Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med. 2008 Jun;121(6):501-508.e3.
- Al-Zoughool M, Dossus L, Kaaks R, et al: Risk of endometrial cancer in relationship to cigarette smoking: Results from the EPIC study. Int J Cancer 121:2741-2747, 2007
- Levi F, Randimbison L, La Vecchia C. Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974–1994. Ann. Oncol., 9: 1229-1232, 1998
- Madsen BS, Jensen HL, van den Brule AJC, Wohlfahrt J, Frisch M Risk factors for invasive squamous cell carcinoma of the vulva andvagina—Population-based case–control study in Denmark Int. J. Cancer:122,2827–2834 (2008)
- Fehr K et al. Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. J Gynecol Oncol Vol. 24, No. 3:236-241 (2013)
- Yueh-Yun Lin et al. Trends in the Incidence of Human Papillomavirus-Associated Cancers by County-Level Income and Smoking Prevalence in the United States, 2000-2018, JNCI Cancer Spectrum, Volume 6, Issue 2, April 2022
- Office on Smoking and Health (US). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2006
- Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011 Oct;20(4):605-18
- Lo YL, Hsiao CF, Chang GC, Tsai YH, Huang MS, Su WC, Chen YM, Hsin CW, Chang CH, Yang PC, Chen CJ, Hsiung CA. Risk factors for primary lung cancer among never smokers by gender in a matched case-control study. Cancer Causes Control. 2013 Mar;24(3):567-76
- Spitz MR et al. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct;1(5):420-9
- Wang A et al. Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort. Ann Oncol. 2015 Jan;26(1):221-230
- McCarthy WJ, Meza R, Jeon J, Moolgavkar SH. Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models. Risk Anal. 2012 Jul;32 Suppl 1(Suppl 1):S69-84
- Report of the Scientific Committee on Tobacco and Health, Department of Health, 1998
- Secondhand smoke: Review of evidence since 1998. Scientific Committee on Tobacco and Health (SCOTH). Department of Health, 2004
- Stayner L, Bena J, Sasco AJ, et al. Lung cancer risk and workplace exposure to environmental tobacco smoke. Am J Public Health. 2007;97(3):545-551
- Zeng XT, Xiong PA, Wang F et al. Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pac J Cancer Prev 2012;13(6):2687-93
- U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. p274, 2014. Printed with corrections, January 2014
- Anderson LN, Cotterchio M, Mirea L, Ozcelik H, Kreiger N. Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers. Am J Epidemiol. 2012 Feb 15;175(4):289-301
- Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia. 2013 Mar;18(1):15-23
- Tang LY, Chen LJ, Qi ML, Su Y, Su FX, Lin Y, Wang KP, Jia WH, Zhuang ZX, Ren ZF. Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1. Gene. 2013 Jul 25;524(2):84-9
- Dossus L et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014 Apr 15;134(8):1871-88
- Zhang, Z., Li, Z., Zhang, X. et al. Association between secondhand smoke and cancers in adults in the US population. J Cancer Res Clin Oncol (2022)
- Mariano LC, Warnakulasuriya S, Straif K, et al. Secondhand smoke exposure and oral cancer risk: a systematic review and meta-analysis. Tobacco Control 2022;31:597-607
- Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks. Eur Urol. 2016 Sep;70(3):458-66
- Thomas JL, Hecht SS, Luo X, Ming X, Ahluwalia JS, Carmella SG. Thirdhand tobacco smoke: a tobacco-specific lung carcinogen on surfaces in smokers' homes. Nicotine Tob Res. 2014 Jan;16(1):26-32
- Ramírez N, Özel MZ, Lewis AC, Marcé RM, Borrull F, Hamilton JF. Exposure to nitrosamines in thirdhand tobacco smoke increases cancer risk in non-smokers. Environ Int. 2014 Oct;71:139-47
- Yuxin Chen, Neema Adhami, Manuela Martins-Green. Biological markers of harm can be detected in mice exposed for two months to low doses of Third Hand Smoke under conditions that mimic human exposure. Food and Chemical Toxicology. Volume 122, 2018. Pages 95-103
- Salihu, HM et al. Prenatal Tobacco Use and Risk of Stillbirth: A Case—Control and Bidirectional Case—Crossover Study. Nicotine & Tobacco Research, Volume 10, Issue 1, January 2008, Pages 159–166
- Nadhiroh SR, Djokosujono K, Utari DM. The association between secondhand smoke exposure and growth outcomes of children: A systematic literature review. Tob Induc Dis. 2020 Mar 3;18:12
- Zhen Wang, Sara M. May, Suvanee Charoenlap, Regan Pyle, Nancy L. Ott, Khaled Mohammed, Avni Y. Joshi. Effects of secondhand smoke exposure on asthma morbidity and health care utilization in children: a systematic review and meta-analysis. Annals of Allergy, Asthma & Immunology. Volume 115, Issue 5, 2015, Pages 396-401
- Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect. 2007 Jan;115(1):138-45
- Vineis P, Airoldi L, Veglia F. et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005; 330: 277-280
- Troy JD, Grandis JR, Youk AO, Diergaarde B, Romkes M, Weissfeld JL. Childhood passive smoke exposure is associated with adult head and neck cancer. Cancer Epidemiol. 2013 Aug;37(4):417-23
- Norman RE, Ryan A, Grant K, Sitas F, Scott JG. Environmental Contributions to Childhood Cancers. Journal of Environmental Immunology and Toxicology 2:2, 86-98; March/April 2014
- Metayer C at al. Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1600-11
- Milne E, Greenop KR, Scott RJ, Bailey HD, Attia J, Dalla-Pozza L, de Klerk NH, Armstrong BK. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am J Epidemiol. 2012 Jan 1;175(1):43-53
- Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S; Brazilian Collaborative Study Group of Infant Acute Leukemia. Pregnancy, maternal tobacco smoking, and early age leukemia in Brazil. Front Oncol. 2012 Nov 9;2:151
- Boffetta P, Aagnes B, Weiderpass E, Andersen A (2005). Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer, 114: 992–995
- Smita Asthana, MD, Satyanarayana Labani, PhD, Uma Kailash, PhD, Dhirendra N Sinha, MD, Ravi Mehrotra, MD, Association of Smokeless Tobacco Use and Oral Cancer: A Systematic Global Review and Meta-Analysis, Nicotine & Tobacco Research, Volume 21, Issue 9, September 2019, Pages 1162–1171
- Burkey MD, Feirman S, Wang H, Choudhury SR, Grover S, Johnston FM. The association between smokeless tobacco use and pancreatic adenocarcinoma: a systematic review. Cancer Epidemiol. 2014 Dec;38(6):647-53
- Zhou J, Michaud DS, Langevin SM, McClean MD, Eliot M, Kelsey KT. Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England. Int J Cancer. 2013 Apr 15;132(8):1911-7
- Gupta S, Gupta R, Sinha DN, Mehrotra R. Relationship between type of smokeless tobacco & risk of cancer: A systematic review. Indian J Med Res. 2018 Jul;148(1):56-76
- Wyss, AB. Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium, American Journal of Epidemiology, Volume 184, Issue 10, 15 November 2016, Pages 703–716
- Warnakulasuriya S, Straif K. Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals. Indian J Med Res. 2018 Dec;148(6):681-686
- Shihadeh A, Schubert J, Klaiany J, El Sabban M, Luch A, Saliba NA. Toxicant content, physical properties and biological activity of waterpipe tobacco smoke and its tobacco-free alternatives. Tob Control. 2015 Mar;24 Suppl 1(Suppl 1):i22-i30
- Waziry R, Jawad M, Ballout RA, Al Akel M, Akl EA. The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. Int J Epidemiol. 2017 Feb 1;46(1):32-43
- Kadhum M, Sweidan A, Jaffery AE, Al-Saadi A, Madden B. A review of the health effects of smoking shisha. Clin Med (Lond). 2015 Jun;15(3):263-6
- Al-Amad SH, Awad MA, Nimri O. Oral cancer in young Jordanians: potential association with frequency of narghile smoking. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Nov;118(5):560-5
- Jacob P 3rd, Abu Raddaha AH, Dempsey D, Havel C, Peng M, Yu L, Benowitz NL. Comparison of nicotine and carcinogen exposure with water pipe and cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):765-72
- Munshi T, Heckman CJ, Darlow S. Association between tobacco waterpipe smoking and head and neck conditions: A systematic review. J Am Dent Assoc. 2015 Oct;146(10):760-6
- El-Zaatari ZM, Chami HA, Zaatari GS. Health effects associated with waterpipe smoking. Tob Control. 2015 Mar;24 Suppl 1(Suppl 1):i31-i43
- Montazeri Z, Nyiraneza C, El-Katerji H, et al. Waterpipe smoking and cancer: systematic review and meta-analysis Tobacco Control 2017;26:92-97
- Darawshy F, Rmeileh AA, Kuint R, Berkman N. Waterpipe smoking: a review of pulmonary and health effects. European Respiratory Review 2021 30: 200374
- Maziak W. The waterpipe: an emerging global risk for cancer. Cancer Epidemiol. 2013 Feb;37(1):1-4
- Chang CM, Corey CG, Rostron BL, Apelberg BJ. Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health. 2015 Apr 24;15:390
- Malhotra J et al.; Association between Cigar or Pipe Smoking and Cancer Risk in Men: A Pooled Analysis of Five Cohort Studies. Cancer Prev Res (Phila) 1 December 2017; 10 (12): 704–709